Gault Cheryl (CIK 1839046) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Sell RAPP (1,900 shares), Sell RAPP (3,792 shares), Sell RAPP (3,308 shares), Sell RAPP (1,000 shares), Sell RAPP (7,161 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Sell | 1,900 | $76,174 |
| 2026-07-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Sell | 3,792 | $156,964 |
| 2026-07-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Sell | 3,308 | $139,506 |
| 2026-07-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Sell | 1,000 | $43,155 |
| 2026-03-31 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Sell | 7,161 | $200,794 |
| 2026-03-31 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Sell | 2,839 | $81,053 |
| 2026-03-09 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Sell | 2,014 | $58,265 |
| 2025-12-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Buy | 5,000 | $9,000 |
| 2025-12-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Sell | 5,000 | $150,500 |
| 2025-09-10 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Buy | 5,000 | $9,000 |
| 2025-09-10 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Sell | 5,000 | $191,650 |
| 2025-03-05 | Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | Buy | 13,987 | $0 |
Source: SEC Form 4 filings · as of 2026-07-01